溶栓治疗已成为十余年来急性心肌梗塞的主要治疗进展之一，其益处在于使得由于血栓阻塞的冠状动脉在短时间内再通。更为重要的是在症状出现的几小时内冠脉得以完全再通的患者生存率、左室功能及心肌存活都有不同程度的提高。冠状动脉再通后的血流分级常用心肌梗塞溶栓疗法... Thrombolytic therapy has become one of the major therapeutic advances in acute myocardial infarction over more than a decade, with the benefit of allowing recanalization of the coronary artery due to thrombus occlusion within a short period of time. More importantly, the survival rate, left ventricular function, and myocardial viability in patients with coronary recanalization within a few hours of symptom onset were all improved to varying degrees. Coronary artery recanalization after the classification of blood flow thrombolytic therapy with myocardial infarction ...